[Acomplia, an essential medication or a "comfort" product?].
Nau
Jean-Yves
JY
D005858:Germany; D006801:Humans; D007356:Insurance, Pharmaceutical Services / Q000331:legislation & jurisprudence; D009765:Obesity / Q000188:drug therapy; D010880:Piperidines / Q000145:classification* / Q000627:therapeutic use; D011720:Pyrazoles / Q000145:classification* / Q000627:therapeutic use; D043884:Receptor, Cannabinoid, CB1 / Q000037:antagonists & inhibitors*; D000077285:Rimonabant
D010880:Piperidines; D011720:Pyrazoles; D043884:Receptor, Cannabinoid, CB1; D000077285:Rimonabant